Related Experiment Video
Updated: Apr 17, 2026

10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
13.0K
Ige-mediated food allergy - current problems and future perspectives (review)
N Lomidze1, T Gotua1, M Gotua1
1Center of Allergy and Immunology; Tbilisi State Medical University, Georgia.
Georgian Medical News
|February 19, 2015
Summary
Food allergy (FA) prevalence is rising, affecting 17.3% self-reported vs. 0.9% confirmed. Management includes avoidance, emergency plans, and emerging oral immunotherapy (OIT).
Area of Science:
- Immunology
- Allergy and Immunology
- Pediatric Allergy
Background:
- Rising incidence and prevalence of food allergy (FA) observed over the past 10-20 years.
- Self-reported FA prevalence is 17.3%, significantly higher than the 0.9% confirmed by challenge.
- Eight major foods (cow's milk, egg, wheat, soy, peanut, tree nuts, fish, shellfish) are primary causes of FA.
Purpose of the Study:
- To review the current understanding of food allergy (FA) epidemiology, diagnosis, and management.
- To highlight the discrepancy between self-reported and confirmed FA prevalence.
- To discuss emerging therapeutic strategies like oral immunotherapy (OIT).
Main Methods:
- Review of recent epidemiological studies on FA prevalence.
- Summary of diagnostic methods including skin prick tests (SPT), specific IgE (sIgE), component-resolved diagnostics (CRD), and double-blind placebo-controlled food challenges (DBPCFC).
- Discussion of current and investigational treatment modalities.
Main Results:
- A significant increase in FA prevalence is suggested by recent studies.
- Clinical manifestations range from skin and gastrointestinal reactions to life-threatening anaphylaxis.
- Strict avoidance and emergency preparedness (epinephrine autoinjector) are current management cornerstones.
Conclusions:
- Exclusive breastfeeding for 4-6 months is recommended without maternal dietary restrictions.
- Oral immunotherapy (OIT) shows promise for desensitization but requires further research for long-term safety and efficacy.
- Continued research is essential to integrate novel therapies like OIT into mainstream FA care.

